Sanjiv J. Shah

Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis

Sanjiv J. Shah, M. Gheorghiade, A. Morgan, 2013, The Lancet.

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

D. Kitzman, V. Melenovský, D. Lewinski, 2024, The Lancet.

Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial.

D. Kitzman, R. McGarrah, Sheryl L. Windsor, 2024, JACC. Heart failure.

Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial.

D. Kitzman, A. Voors, S. Perl, 2024, JAMA cardiology.

Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey

Anthony Hoovler, Javed Butler, Sanjiv J. Shah, 2024, BMC primary care.

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.

D. Kitzman, S. Z. Abildstrom, B. Merkely, 2024, Journal of the American College of Cardiology.